Searched for
HEALTHCARE EARNINGS INDIA
Rs 1.5 lakh crore behind 2025! Can Jio, NSE and other mega IPOs put 2026 on course for another record year?India's primary market faces a significant fundraising gap to match last year's record. However, upcoming mega IPOs from Reliance Jio (Rs 3...- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- CSM Technologies IPO opens: Check brokerage review, GMP and other detailsThe IPO will remain open until June 26. It is a book-built issue with a price band of Rs 147-155 per share. The issue comprises a fresh iss...
- India’s next big challenge: From welfare delivery to human developmentThe National Family Health Survey 2023-24 reveals India's success in expanding welfare delivery and essential service access, reaching near...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- He made cooking safe for all Indian, gave away his business patent for free: Meet Padma awardee Prestige cooker owner TT Jagganth who turned a near-bankrupt firm into one of most recognised cookwareLate industrialist T. T. Jagannathan, the visionary behind the Gasket Release System that revolutionized pressure cooker safety, will be ho...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Rs 9,500 for 20 minutes to fix a door: Indian woman in US gives reality check on skilled workers’ earningsAn Indian woman in the US shared her experience of paying $100 for a 20-minute garage door repair, highlighting the high value placed on sk...
- Smallcap funds beat all equity mutual fund categories over 3 months. Should investors change SIP strategy?Smallcap funds have emerged as the best-performing equity mutual fund category over the last three months, delivering an average return of ...
- Tribal girl watched her father heal the sick; that inherited wisdom made her the ‘Queen of Herbs’, helping over 300,000 patients battle deadly diseasesYanung Jamoh Lego, popularly known as the 'Adi Queen of Herbs', is a traditional healer from Arunachal Pradesh who has spent more than thre...
- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- ET Alpha Wealth Summit | FIIs haven't abandoned India, they've just reshuffled: Samir AroraForeign investors are not leaving India. They are shifting investments from top companies to other stocks. This rotation involves billions ...
- Financials in a sweet spot, defence remains a structural bet: Dharmesh KantFinancial stocks are set to lead a market rally through June and July. Experts see banks and financial institutions benefiting from strong ...
- Cloudnine's 25% stake sale attracts top global PE firmsLeading global private equity firms are in the running to acquire a substantial minority stake in Cloudnine, India's premier maternity and ...
- India's structural growth story remains strong despite global uncertainties: VenturaIndia's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
Load More
